FDA’s Independent Advisory Panel Votes in Favor of Two RSV Vaccines
March 2, 2023
The FDA’s independent advisory panel voted in favor of two vaccines for respiratory syncytial virus (RSV). The vaccines, developed by GSK and Pfizer for people